Cutaneous myxovirus resistance protein A expression is associated with quantitative CT abnormalities in dermatomyositis-associated interstitial lung disease

Dermatomyositis-associated interstitial lung disease (ILD) is thought to involve type I interferon–mediated inflammation; however, clinical evidence for systemic interferon activation in ILD remains limited. We investigated whether cutaneous myxovirus resistance protein A (MxA), a type I interferon–inducible protein, is associated with pulmonary abnormalities on quantitative CT in patients with dermatomyositis. We retrospectively studied 24 patients who underwent diagnostic skin biopsy, including 18 with ILD. Cutaneous MxA immunostaining was evaluated across five anatomical compartments (total score, 0–15). Quantitative total ILD extent and consolidation/ground-glass opacity extent were evaluated on high-resolution CT using deep learning–based software. Associations were assessed using Spearman correlation. MxA expression was higher in anti–melanoma differentiation–associated gene 5–positive patients than anti-MDA5-negative patients (median 14.0 [interquartile range 11.0–15.0] vs 10.5 [6.0–13.0], p = 0.03) and correlated positively with serum ferritin (ρ = 0.43, p = 0.043). MxA expression correlated with quantitative total ILD extent (ρ = 0.46, p = 0.02) and consolidation/ground-glass opacity extent (ρ = 0.49, p = 0.01). Positive but weaker, nonsignificant correlations were observed in analyses restricted to patients with ILD. Cutaneous MxA expression was associated with the extent of CT abnormalities in dermatomyositis, suggesting a potential relationship between cutaneous interferon-related activity and pulmonary involvement.

Authors

Publication Details

Journal
Figshare
Published
2026-11-21
DOI
https://doi.org/10.6084/m9.figshare.35083333
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cutaneous myxovirus resistance protein A expression is associated with quantitative CT abnormalities in dermatomyositis-associated interstitial lung disease

Hajime Sakuma, Toru Ogura, Ayako Nakajima, Shuichi Murashima et al.
Figshare
Inflammatory Myopathies and Dermatomyositis
article

Cutaneous myxovirus resistance protein A expression is associated with quantitative CT abnormalities in dermatomyositis-associated interstitial lung disease

Hajime Sakuma, Toru Ogura, Ayako Nakajima, Shuichi Murashima, Yasutaka Ichikawa, Hiroshi Imai, Hiroto Yuasa, Yuhei Ito, Yoshiyuki Arinuma
article en

Abstract

Dermatomyositis-associated interstitial lung disease (ILD) is thought to involve type I interferon–mediated inflammation; however, clinical evidence for systemic interferon activation in ILD remains limited. We investigated whether cutaneous myxovirus resistance protein A (MxA), a type I interferon–inducible protein, is associated with pulmonary abnormalities on quantitative CT in patients with dermatomyositis. We retrospectively studied 24 patients who underwent diagnostic skin biopsy, including 18 with ILD. Cutaneous MxA immunostaining was evaluated across five anatomical compartments (total score, 0–15). Quantitative total ILD extent and consolidation/ground-glass opacity extent were evaluated on high-resolution CT using deep learning–based software. Associations were assessed using Spearman correlation. MxA expression was higher in anti–melanoma differentiation–associated gene 5–positive patients than anti-MDA5-negative patients (median 14.0 [interquartile range 11.0–15.0] vs 10.5 [6.0–13.0], p = 0.03) and correlated positively with serum ferritin (ρ = 0.43, p = 0.043). MxA expression correlated with quantitative total ILD extent (ρ = 0.46, p = 0.02) and consolidation/ground-glass opacity extent (ρ = 0.49, p = 0.01). Positive but weaker, nonsignificant correlations were observed in analyses restricted to patients with ILD. Cutaneous MxA expression was associated with the extent of CT abnormalities in dermatomyositis, suggesting a potential relationship between cutaneous interferon-related activity and pulmonary involvement.

Figshare
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Cutaneous myxovirus resistance protein A expression is associated with quantitative CT abnormalities in dermatomyositis-associated interstitial lung disease — Hajime Sakuma, Toru Ogura, et al. · Figshare (2026) | TGRS Research Map | TGRS